Breaking News, Promotions & Moves

Harbour BioMed Appoints Raymond Zheng as Chief Business Officer

Zheng will lead global business development and alliance management functions.

Author Image

By: Charlie Sternberg

Associate Editor

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, has appointed Dr. Raymond Zheng as Chief Business Officer (CBO).   Based in the United States, Zheng will lead global business development and alliance management functions, reporting directly to Dr. Jingsong Wang, Founder, Chairman and CEO of Harbour BioMed.   In his new role, Zheng will seek to maximize the val...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters